26
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Large-Scale Synthesis of Oligodeoxyribonucleotide Phosphorothioate Using Controlled-Pore Glass as Support

, , , &
Pages 1219-1226 | Received 12 Sep 1994, Accepted 28 Nov 1994, Published online: 24 Sep 2006

References

  • Andrade , M. , Scozzari , A. , Cole , D. L. and Ravikumar , V. T. 1994 . Bioorg. Med. Chem. Lett. , 4 : 2017 Part 4 on Process Improvement Chemistry (PIC). For Part 3, refer to
  • Uhlmann , E. and Peyman , A. 1990 . Chem. Rev. , 90 : 543
  • Cook , P. D. 1991 . Anti-Cancer Drug Des. , 6 : 585
  • Crooke , S. T. and Lebleu , B. 1993 . Antisense Research and Applications , Boca Raton : CRC Press .
  • Milligan , J. F. , Matteucci , M. D. and Martin , J. C. 1993 . J. Med. Chem. , 36 : 1923
  • Stein , C. A. and Cheng , Y.-C. 1993 . Science , 261 : 1004
  • Agrawal , S. 1993 . Protocols for Oligonucleotides and Analogs: Synthesis and Properties , Vol. 20 , Totowa : Humana Press .
  • Bennett , C. F. , Condon , T. P. , Grimm , S. , Chan , H. and Chiang , M.-Y. 1994 . J. Immunol , 152 : 3530
  • Crooke , S. T. 1994 . Annual Meeting of the Federation of American Society of Experimental Biology (FASEB), Anaheim, CA , April 28
  • Sanghvi , Y. S. 1993 . Antisense Research and Applications , Edited by: Crooke , S. T. and Lebleu , B. Boca Raton : CRC Press .
  • Varma , R. S. 1993 . SYNLETT , 621
  • It is roughly estimated that for a systemic dosing for treatment of a chronic disease, about 700 to 900 kilos/year of drug is needed to meet the present demand.
  • Wright , P. , Lloyd , D. , Rapp , W. and Andrus , A. 1993 . Tetrahedron Lett. , 34 : 3373
  • Murphy , M. , Rieger , M. and Jayaraman , K. 1993 . BioTechniques , 15 : 1004
  • The user manual for Milligen 8800 suggests using 15 g of CPG as the upper limit of synthetic scale. However, we were able to use 50 g of CPG successfully without any problem.
  • Iyer , R. P. , Egan , W. , Regan , J. B. and Beaucage , S. L. 1990 . J. Am. Chem. Soc. , 112 : 1253
  • Iyer , R. P. , Philips , L. R. , Egan , W. , Regan , J. B. and Beaucage , S. L. 1990 . J. Org. Chem. , 55 : 4693
  • The reactor vessel uses an inert gas for fluidization of the support in the reaction mixture. Subsequently, excess reagents used in the synthetic cycle are removed by dilution followed by filtration. Due to high carry over of reagents contained in the pores of CPG (up to 40%),44 displacement of reagents by dilution requires multiple washes of the support. Experiments performed in our laboratories have demonstrated that effective removal of excess reagent is observed with washing carried out without gas driven agitation. This technique is especially effective during detritylation, due to the non-equilibrium conditions, thereby suppressing the reversibility of detritylation reaction.
  • Christodoulou , C. 1993 . Protocols for Oligonucleotides & Analogs: Synthesis and Properties , Edited by: Agrawal , S. Vol. 20 , pp 23 Totowa : Humana Press .
  • Bergot , B. J. and Egan , W. 1992 . J. Chromatogr. , 599 : 35
  • Kato , Y. , Kitamura , T. , Mitsui , A. , Yamasaki , Y. and Hashimoto , T. 1988 . J. Chromatogr. , 447 : 212
  • Metelev , V. and Agrawal , S. 1992 . Anal. Biochem. , 300 : 342
  • Coomber , B. A. 1985 . Biochimie , 67 : 797
  • Cohen , A. S. , Vilenchik , M. , Dudley , J. L. , Gemborys , M. W. and Bourque , A. J. 1993 . J. Chromatogr. , 638 : 292
  • Warren , W. J. and Vella , G. 1993 . BioTechniques , 14 : 598
  • Oefner , P. J. , Bonn , G. K. , Huber , C. G. and Nathakarnkitkool , S. 1992 . J. Chromatogr. , 625 : 331
  • Meyer , A. 1991 . Arch. Pathol. Lab. Med. , 115 : 1228
  • Andrus , A. 1992 . METHODS: A Companion to Methods in Enzymology , 4 : 213
  • Little , D. P. , Chorush , R. A. , Speir , J. P. , Senko , M. W. , Kelleher , N. L. and McLafferty , F. W. 1994 . J. Am. Chem. Soc. , 116 : 4893
  • Schuette , J. , Cole , D. L. and Srivatsa , G. S. 1994 . J. Pharm. Biomed. Anal. , in press
  • Agrawal , S. , Tang , J. Y. and Brown , D. M. 1990 . J. Chromatogr. , 509 : 396
  • Maxam , A. M. and Gilbert , W. 1977 . Proc. Natl. Acad. Sci. USA , 74 : 560
  • Wyrzykiewicz , T. K. and Cole , D. L. 1994 . Nucleic Acids Res. , 22 : 2667
  • Pieles , U. , Zürcher , W. , Schär , M. and Moser , H. E. 1994 . Nucleic Acids Res. , 21 : 3191
  • Keough , T. , Baker , T. R. , Dobson , R. L. M. , Lacey , M. P. , Riley , T. A. , Hasselfield , J. A. and Hesselberth , P. E. 1993 . Rapid Commun. Mass Spectr. , 7 : 195
  • Fitzgerald , M. C. , Zhu , L. and Smith , L. M. 1993 . Rapid Commun. Mass Spectr. , 7 : 895
  • Anderson , N. G. , Anderson , N. L. , Taylor , J. and Goodman , J. 1994 . Frontiers in Bioprocessing III , University of Colorado . in press
  • Anderson , N. G. , Anderson , N. L. , Taylor , J. and Goodman , J. 1993 . Innovations and Perspectives in Solid Phase Synthesis pp 1 Oxford
  • Scremin , C. L. , Zhou , L. , Srinivasachar , K. and Beaucage , S. L. 1994 . J. Org. Chem. , 59 : 1963
  • Brill , W. K. D. 1994 . Tetrahedron Lett. , 35 : 3041
  • The cost of synthesis of these oligonucleotides as compared to five years ago ($ 18,000/g) has been reduced by an order of magnitude and the estimated raw material cost has been projected to be $300/g for systemic therapy.
  • Scozzari , A. 1994 . BioWest Pacific Rim Biotechnology Conference . June 7–9 1994 , San Diego, CA.
  • Arnold , L. 1994 . American Association of Pharmaceutical Scientist Western Regional Meeting . March 24–25 1994 , San Francisco, CA.
  • Haller , W. 1983 . Solid Phase Biochemistry: analytical and synthetic aspects , Edited by: Scouten , W. H. pp 535 – 97 . New York : Wiley .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.